²Ä 156 ´Á 2006-06-29

·|ij³ø¾É
°ê®a½Ã¥Í¬ã¨s°|²Ä¥|©¡²Óµß°ò¦]½Õ±±»P­P¯f¾÷Âà¬ã°Q·|¬ö­n

½t°_
¥Á°ê¤E¤Q¦~®L¤Ñ¤§¦~«×«D¥¿¦¡²Óµß¬ã°Q·|ªº»E·|¸Ì¡A¼B¥@ªF±Ð±Â´£¨ì¥Ñ°ê®a½Ã¥Í¬ã¨s°|©ÒÁ|¿ìªº¬ã°Q·|¤¤¿W¯Ê²Óµß¾Ç»â°ì¡C¨Æ¹ê¤W¡A±q¨Æ²Óµß¾Ç¬ã¨s¤§¥»°ê¾ÇªÌ¤w³v¤é¼W¦h¡AÀ³¥i½Ð°ê®a½Ã¥Í¬ã¨s°|¨ó§UÁ|¿ì¨ã°ê»Ú¤Æ¤§²Óµß¬ã°Q·|¡C©ó¬O¡A¦b´X¦ì±Ð±Âªº¿n·¥µ¦¹º¤§¤U¡A©ó¤E¤Q¤@¦~¥|¤ë¤G¤Q¤»¤é¥H¤Î¤G¤Q¤C¤é¨â¤Ñ¡A¦b®ç¶é¿¤Às¼æ¶m§»ùÖ´÷±æ¾Ç²ß¤¤¤ßÁ|¿ì¤F­º©¡ªº¡u²Óµß°ò¦]½Õ±±»P­P¯f¾÷Âà¬ã°Q·|¡v¡C¥Ñ©ó²Ä¤@©¡«Y­º«×¹Á¸ÕÁpô°ê¤º±q¨Æ»P²Óµß°ò¦]½Õ±±»P­P¯f¾÷Âà¬ÛÃö¬ã¨s¤§¾ÇªÌ¦P»E¤@°ó¥æ´«¸gÅç»P¤ß±o¡A¬G¼È¥¼ÁܽХ~°ê¾ÇªÌ°Ñ»P¡C·|«á©Ò¦³°Ñ»PªÌ¤ÏÀ³¼ö¯P¡A¨Ã¨M©w¤@¦~«áÄò¿ì¦¹¬ã°Q·|¡CµM¦]SARS¤§µo¥Í¡A²Ä¤G©¡¤§¡u²Óµß°ò¦]½Õ±±»P­P¯f¾÷Âà¬ã°Q·|¡v©µ¦Ü¤E¤Q¤T¦~¥|¤ë¤G¤Q¥|¤é¥H¤Î¤G¤Q¤­¤é¨â¤Ñ©ó¦P¤@¦aÂIÁ|¦æ¡C¨ä«á²Ä¤T©¡¤Î²Ä¥|©¡¤§¡y²Óµß°ò¦]½Õ±±»P­P¯f¾÷Âà¬ã°Q·|¡z¦]°ê®a½Ã¥Í¬ã¨s°|©ó¦Ë«n«Ø°|§¹¦¨¡A¬G¤À§O©ó¤E¤Q¥|¦~¥|¤ë¤T¤Q¤é¦Ü¤­¤ë¤@¤é¡A¤E¤Q¤­¦~¥|¤ë¤G¤Q£¸¤é¦Ü¤G¤Q¤G¤é©ó¦Ë«n°ê®a½Ã¥Í¬ã¨s°|°|°ÏÁ|¦æ¡C¦¹¤G¦¸·|ij¬Ò¥Ñ¤ýÀA°ó¡B¦óº§º¬¡B§d«T©¾¡B­J¤p´@¡B±i®Ì·ß¡B´^¼z¬Â¡B¼B¥@ªF¡B¿à«H§Óµ¥¾á¥ôÄw³Æ©e­û¡A¨Ã¥Ñ²Ä¤G©¡°_¨C¦¸·|ij¬ÒÁܽШâ¦W°ê¥~ª¾¦W¾ÇªÌ»P·|¡A©Ò¦³¤fÀY¤Î®Ñ­±³ø§i¬Ò¥H­^¤åµoªí¡C

·|ij¤º®e·§­z
¥»©¡¬ã°Q·|°Ñ¥[ªÌ¬ù70¤H¡]¥]¬A11¦W´£¥X¬ã¨s¦¨ªGªº³Õ¤h¯Z¾Ç¥Í¤Î¬ã¨s¾ÇªÌ¡^¡A¥]§t¤T­Ó¥DÃD¡A¤À§O¬°¡u±J¥D»P²Óµß¤§¬Û¤¬§@¥Î¡]Host-Bacterial Interaction¡^¡v¡A¡u²Óµß­P¯f¾÷Âà¡]Bacterial Pathogenesis¡^¡v©M¡uµ²ºc¥Íª«¾Ç¡]Structure Biology¡^¡v¡C²Ä¤@­Ó¥DÃD§t¦³¤@­Ó¯S§OºtÁ¿©M¤­­Ó¤fÀY³ø§i¡F²Ä¤G­Ó¥DÃD§t¦³¤T­Ó¤fÀY³ø§i¡F²Ä¤T­Ó¥DÃD«h§t¦³¤@­Ó¯S§OºtÁ¿©M¤T­Ó¤fÀY³ø§i¡C¨C¦¸ªº¯S§OºtÁ¿®É¶¡¬ù1¤p®É¡A¦Ó¤fÀY³ø§i«h¬°25¤ÀÄÁ¡C

¦b²Ä¤@­Ó¥DÃD¡u±J¥D»P²Óµß¤§¬Û¤¬§@¥Î¡]Host-Bacterial Interaction¡^¡v·í¤¤¡A­º¥ý¥Ñ¬ü°ê«¢¦ò¤j¾ÇªºEric Rubin±Ð±Â¡]Department of Immunology and Infectious Diseases, Harvard School of Public Health, USA¡^µ¹¤©¤@³õ¯S§OºtÁ¿¡A¨äÁ¿ÃD¬°¡G§Q¥ÎÂà¦ì¤l³¡¦ìÂø¥æ§Þ³N(Transposon Site Hybridization, TraSH)¬ã¨s¤ÀªK±ìµß(Mycobacterium)¤§°ò¦]Åé¡CRubin±Ð±Â­º¥ý§Q¥ÎÂà¦ì¤l¬ðÅܪk«Ø¥ß¤F¤ÀªK±ìµß¤§¬ðÅÜ®è¡A¨C¤@¬ðÅÜ®è¶È±a¤@­ÓÀH·N´¡¤J¤§Âà¦ì¤l¡A¦A§Q¥ÎDNA·L°}¦C(microarrays)¤j¶q©w¥XÂà¦ì¤l´¡¤J¤§³¡¦ì¡A¦]¤§µo®i¥XÂà¦ì¤l³¡¦ìÂø¥æ§Þ³N¡A¦¹§Þ³N¥i¥Î¨Ó¤ñ¸û¥X­þ¨Ç°ò¦]¬°²Óµß¥Íªø©Ò¥²»Ý¡A¬G¦ÓµLÂà¦ì¤l¤§´¡¤J¡CRubin±Ð±Â¤]§Q¥Î³J¥Õ½èÅé¾ÇŲ©w¤F­þ¨Ç°ò¦]»P²Óµß¤§¬r¤O¦³Ãö¡A¨ä¤¤·sµo²{¤§ESX-1¥ç¬°³J¥Õ½è¤Àªc¨t²Î¤§­«­n¦¨¥÷¡C

±µµÛ¡A¤¤¥¡¬ã¨s°|´Óª«º[·L¥Íª«¾Ç¬ã¨s©Ò¶ÀµqÞ±³Õ¤hµoªíTzs³J¥Õ½è¬°´Óª«²ÓµßAgrobacterium tumefaciens¥Íªø©Ò¥²¶·¡C¦¨¤j·L¥Íª«¤Î§K¬Ì¾Ç¬ã¨s©ÒªL¥H¦æ±Ð±Â³ø§i¤FÃì²yµß¤§¤ÆÁw©Ê¥~¬r¯À(Streptococcal pyrogenic exotosin B)¥iÂǥѳJ¥Õ½èS¤§¤Á³Î¨Ó§í¨î¥¨¾½²Ó­M²M°£­ä¤`¤§²Ó­M¡C¥x¤j·L¥Íª«¾Ç¬ì¸ë´º¤s±Ð±Â¤¶²Ð¤FÃì²yµß¤§¸²µå¿}Âಾ»Ã¯À(Glucosyltransferase)»P¤º¥Ö²Ó­M(endothelial cell)¤§¥æ¤¬§@¥Î¹ï·P¬V©Ê¤ß¤º½¤ª¢(infective endocarditis) ¤§§K¬Ì­P¯f¦]¡Cªø©°¤j¾Ç·L¥Íª«¤Î§K¬Ì¾Ç¬ìÁ¸h¯]±Ð±Â¤¶²Ð¤F¦b§J¹p§B¤óªÍª¢±ìµß(Klebsiella pneumoniae)·P¬V¤§¤HÃþ¨xÀù²Ó­M®èHepG2¨ä¤¤¤§Mitogen activated protein (MAP) kinase ·|¬¡¤Æ¡C³Ì«á¡A¶§©ú¤j¾Ç·L¥Íª«¤Î§K¬Ì©Ò³\¸UªK±Ð±Â³ø§i¤F¥X¦å©Ê¤j¸z±ìµßEnterohemorrhagic E. coli O157:H7¤§­P¯f®qÀ¬(pathogenicity island)¤¤°ò¦]ªí²{¤§½Õ±±¡C

¦b²Ä¤G³¡¥÷¡u²Óµß­P¯f¾÷Âà (Bacterial Pathogenesis)¡vªº¥DÃD·í¤¤¡A­º¥ý¥Ñ¦¨¤j·L¥Íª«¤Î§K¬Ì¾Ç¬ã¨s©Ò¦óº§º¬±Ð±Â³ø§i¤F²Ä¤G¥Íª««¬³Ð¶Ë©·µß²Åµß®è¤¤(Biotype 2 Vibrio vulnificus) ¨ã¦³¬r¤O¤§½èÅé¨ä®Ö¥Ì»Ä§Ç¦C¤ÀªR¤Î¯S©Ê¤§¬ã¨s¡C±µµÛ¡A¤¤¥¡¬ã¨s°|´Óª«º[·L¥Íª«¾Ç¬ã¨s©Ò½²汮Às³Õ¤hµoªí¦p¦ó§Q¥Î°°³æ­M²ÓµßPseudomonas putida YLFP14¨Ó±±¨î²¢´Ô¤§²Óµß´³ÂI¯f¤Î¨ä¬ÛÃö¤§¾÷¨î¡C¦PÄݸӳæ¦ì¤§¿àº¸珉±Ð±Â«h³ø§i¤F¥H³J¥Õ½èÅé¾Ç¤ÀªR¤F­þ¨Ç°ò¦]»P´Óª«²ÓµßAgrobacterium tumefaciens¤§¬r¤O¦³Ãö¡C

¦b²Ä¤T³¡¥÷¡uµ²ºc¥Íª«¾Ç¡]Structure Biology¡^¡vªº¥DÃD¤¤¡A­º¥ý¥Ñ¬ü°êScripps¬ã¨s©ÒªºJames A. Hoch±Ð±Â¡]Department of Molecular and Experimental Medicine, The Scripps Research Institute, USA¡^µ¹¤©¤@³õ¯S§OºtÁ¿¡C¨äÁ¿ÃD¬°¡G²Óµßªº¨âºØ¤À¤l°T®§¶Ç¾É¨t²Î¤¤¤À¤l¯S²§©Ê¤§ºt¤Æ¡C²Óµßªº¨âºØ¤À¤l°T®§¶Ç¾É¨t²Î¥]§t¤@­Ó·P´ú°T®§ªºHistidine kinase¤Î¤@­Ó¤ÏÀ³½Õ±±Âà¿ý¦]¤l¡A¥i±NÀô¹Ò¤Î²Ó­Mªº°T®§Âà´«¦¨°ò¦]¤§ªí²{©Î¦æ¬°¤§§ïÅÜ¡C¦¹¨âºØ¤À¤l¤§¶¡ªº¥æ¤¬§@¥Î¦³¨ä¯S²§©Ê¡AHoch±Ð±Â§Q¥Î·sªº¼Æ¾Ç¤èªk¤ÀªR°ò¦]¸ê®Æ¡A¦A¦X¨Ö¤À¤l¤§´¹Åéµ²ºc¡AÂǦ¹¥HÀ˵ø¦¹¨âºØ¤À¤l¤§¶¡ªº¥æ¤¬§@¥Î¡AHoch±Ð±Â©Ò«Ø¥ßªº¤èªk¥iÅã¥Ü¦b¨â¤À¤l¥æ¤¬§@¥Îªºªí­±¦p¦óºt¤Æ¥X¯S²§©Ê¡A¥H¤Î¦p¦óµo²{­t³d¿ï¾Ü©ÊªºÓi°ò»Ä¡C±µµÛ¥Ñ¤¤¥¡¬ã¨s°|¥Í¤Æ©ÒªL«T§»³Õ¤h¤¶²Ð«Õªù±ìµß(Helicobacter pylori)¤§£\1,3-Fucosyltransferase¨äCºÝ¨M©w¤F¦¹»Ã¯À¤§µ²ºc¤Îí©w©Ê¡C¤¸´¼¤j¾Ç¥Íª«¬ì§Þ¤Î¥Íª«¸ê°T¬ã¨s©Òªº±d¥@¦°±Ð±Â¡A¤¶²Ð¤F»PÂ×­ì¯À¯×ªÕ»Ä¦X¦¨¦³Ãöªº°ò¦]¤§¬ã¨s¡Aªø©°¤j¾Ç·L¥Íª«¤Î§K¬Ì¾Ç¬ìªº§d©Ó¦t³Õ¤h¤¶²Ð³J¥Õ½è¦X¦¨»Ã¯À½Æ¦Xª«¤§§Î¦¨¡A¬°¦X¦¨Â×­ì¯À©Ò¥²¶·¡C

¦¹¦¸¬ã°Q·|ÁÙ¦³¤Q£¸­Ó¾À³ø®i¥Ü¬ã¨s¦¨ªG¡A¾À³øªº¤º®e¥ç²[»\¤W­z¤T­Ó¥DÃD¡A¬ã¨sªº¤º®e¤]¬Û·íºëªö¡C

¦@ÃÑ»P¨Mij
¤@¡B¥»¬ã°Q·|¤µ«áÄ~Äò¨C¦~Á|¦æ¤@¦¸¡A¨Ã³q¹L¥Ñªø©°¤j¾Ç·L¥Íª«¤Î§K¬Ì¾Ç¬ìÁ¸h¯]±Ð±Â¾á¥ô¤U©¡Äw³Æ©e­û·|¥l¶°¤H¡C

¤G¡B¦p¦P©¹¦~¡A°Ñ¥[ªÌ¤´§Æ±æ¯à°÷¶}©ñ§ó¦h¤H³ø¦W¡A¥H¹Å´f§ó¦hºÓ³Õ¤h¯Z¾Ç¥Í¡A¨Ã¼W¶i¸ó»â°ì¬ã¨s¤H­û¶¡¤§¤¬¬Û¥æ¬y¡C°ê¥~¤§¬ã¨sªÌ¤è­±¡A§Æ±æ¥iÂX¤Î¦Ü¾Fªñ¦pÁú¡B¤é¦U°ê¤§¾ÇªÌ¡AÁܽШä§@¤fÀY³ø§i©Î´£¥X¾À³ø½×¤å¡C

¤T¡B°ê¤º¦³Ãö·P¬Vªº¬ã¨s¬Û·í¦h¡A¥¼¨Ó¥i¦hÁÜÁ{§ÉÂå®v°Ñ»P¡C¥t§ÜÃĩʪº¬ã¨s¥ç¥i¦C¤J¤U¦¸ªº¥DÃD¡C
¡m¤å/¹Ï¡G°|¥~³B´£¨Ñ¡F¤å¡G­J¤p´@¡]¶§©ú¤j¾Ç·L¥Íª«¤Î§K¬Ì¾Ç¬ã¨s©Ò±Ð±Â¡^¡F¹Ï¡G»P·|¤H­û¦X¼v¡A«e±Æ¥ª°_¬°³¯®¶¶§¥N²z³Bªø¡A³\¸UªK±Ð±Â¡ADr. Eric Rubin¡ADr. James A. Hoch¡A­J¤p´@±Ð±Â¡n

°|°È¬ö¨Æ
°ê½Ã°|¡u¦Ñ¦~Âå¾Ç¦¸±M¬ìÂå®v°V½m­pµe¡v²Ä¤G´Áµ²°V

°ê®a½Ã¥Í¬ã¨s°|¡u¦Ñ¦~Âå¾Ç¦¸±M¬ìÂå®v°V½m¡v²Ä¤G´Á8¦ì¾Ç­ûµ²°V¨å§¡A©ó6¤ë24¤é¡A»O¤jÂå°|°ê»Ú·|ij¤¤¤ßÁ|¦æ¡C½Ã¥Í¸p°ê¥Á°·±d§½°Æ§½ªø§d¨q­^¡B°ê½Ã°|¥N²z°|ªø±ç½é¸q¡B¥x¥_¤¯ÀÙÂå°|°|ªøÀ¹ªF­ì¤Î°ê½Ã°|¦Ñ¦~Âå¾Ç¬ã¨s²Õ²Õ¥D¥ô³¯¼y¾l³£¿ËÁ{­P¶P¡Cµ²°V¨å§¤§«á¨Ã©ó»O¤jÂå°|°ê»Ú·|ij¤¤¤ß402AB«ÇÁ|¦æ¡u¦Ñ¦~¤H·ÓÅU¤§¸gÀÙ¦Ò¶q¤Îµû¦ô¤èªk¡v°ê»Ú¬ã°Q·|¡C

°ê½Ã°|¦Ñ¦~Âå¾Ç¦¸±M¬ìÂå®v°V½m½Òµ{¦Û93¦~¶}¿ì¡A¸u½Ð¬ü°ê¯Ã¬ù¦è©`¤sÂå¾Ç°|¦Ñ¦~Âå¾Ç¦h¦ì±M®a¨Ó¥x«ü¾É¡A¶}¿ì¥H¨Ó¼s¨ü°ê¤ºÂå¬É­«µø¡C¥h¦~¦b²Ä¤@´Á°ö¨|¥X7¦ìºØ¤lÂå®v¦^¨ì©ÒÄÝÂå°|±À°Ê¦Ñ¦~Âå¾Ç³¡ªºÄw³]¤U¡A¦p¤µ¥x¤jÂå°|¡B¥x¥_ºaÁ`¤Î¤¤°êÂåÃĤj¾Çªþ³]Âå°|¤w¦b¿n·¥Äw³]¦Ñ¦~Âå¾Ç³¡ªù¡AÅ㨣¹ï°ê¤º­¢¤Á»Ý­nªº¦Ñ¦~Âå¾Çªù¶E¤w°_±À°Ê¤§®Ä¡C¤µ¦~µ²·~ªº8¦ì±M¬ìÂå®v¦A¦^¨ì¦UÂå¾Ç¤¤¤ß«á¡A±N¬°¦UÂå¾Ç¤¤¤ß¦Ñ¦~Âå¾Ç³¡ªº«Ø¸m¦A²K¥Í¤O­x¡C

°ê½Ã°|°V½m­p¹º²Ä1´Áªº7¦W¾Ç­û¡A§¡¬O¨Ó¦Û¥þ°êÂå¾Ç¤¤¤ß¥B¨ã¤º¬ì¡B®a®xÂå®v±M¬ìÂå®v©Î¥i³ø¦Ò°Ñ¸Õ¸ê®æªºµ×­^¡Aªí²{¬Û·íÀu²§¡C²Ä2´Á«h±NÂå®v¸ê®æ½d³òÂX¼W¦Ü´_°·¬ì¤Î¯«¸g¬ì¡C¾Ç­û¦b¸g¹L1¦~ªº°V½m¥Bªí²{¨}¦n¡A¥[¤J¦Ñ¦~Âå¾Ç·|¾Ö¦³1¦~·|­û¸ê®æ«á¡A§Y¥i°Ñ¥[¥Ñ¦Ñ¦~Âå¾Ç·|©ÒºÂ¸Õªº¡u¦Ñ¦~Âå¾Ç¦¸±M¬ìÂå®v¡v¦Ò¸Õ¡C§Ú­Ì²`«H¾Ç­û¦b§¹¦¨°V½m«á¥²©w·|¦¨¬°ºØ¤lÂå®v¨Ã¥B¹ï°ê¤º¦Ñ¦~Âå¾Çªºµo®i§êºt­«­nªº¨¤¦â¡C

¥»©¡8¦ìµ²°VªºÂå®v¤À§O¨Ó¦Û¦¨¤jÂå°|¡B»O¤jÂå°|¡B¤¤¤sÂå°|¡B¤T­xÁ`Âå°|¡Bªø©°Âå°|¤Î®ç¶é±Ó²±Âå°|¡C¥Ñ©ó¹L¥h°ê¤ºÂå°|¦b¦Ñ¦~¦¸±M¬ìÂå®vªº¤H¤~°ö¨|¡A¬O¹s¬Pªº±NÂå®v°e¨ì°ê¥~¾Ç²ß¡C³o¤G¦~¨Ó°ê½Ã°|»P¥x¤jÂå°|¤Îªø©°Âå°|Äâ¤â¦X§@¡A³z¹L¦Ñ¦~¦¸±M¬ìÂå®v°V½m½Òµ{«Ø¥ß°ò¦¡A¨Ã¦³­pµeªº°ö¾i¥»¤g¤Æªº¥xÆW¦Ñ¦~Âå¾Ç¦¸±M¬ìÂå®v¡A¥H´Á¸Ñ¨M§Y±N­±Á{ªº¤H¤fµ²ºc°ªÄ֤ƹïÂåÀøÅé¨tªº½ÄÀ»°ÝÃD¡C

¤H¤f°ªÄ֤ƪº¦U¶µ°ÝÃD¤w¬O²{¥N¬F©²³¡ªù¤£®e©¿µøªº­«­n½ÒÃD¡C°£¤F¤H¤~°ö¨|¥~¡A¦Ñ¦~Âå¾Çªº¦U¶µ°·±d«ü¼Ð»P½ÒÃD¬ãÀÀ¡A§ó¬O¥ßªk¤Î¬F©²¬Fµ¦¨î­qªº­«­n°Ñ¦Ò¨Ì¾Ú¡A¬°¤F´£¨Ñ¬F©²¬Fµ¦ªº«Ø¨¥¡A°ê½Ã°|¦Ñ¦~Âå¾Ç¬ã¨s²Õ¯S§OÁܽХ]¬A¿D¬wªºA.L. Howe±Ð±Â¤Î¼w°êTH Lin(ªL§ÓÂE)±Ð±Â¤Î§õ¥@¥N¡B¾G¤å½÷µ¥°ê¤º¡B¥~±M®a¨Ó±´°Q±q¸gÀÙ­±ÁA¸Ñ°ê¤º¦Ñ¦~¤H·ÓÅU¤§°]°È¬Fµ¦ªº¦U¶µ¦]¯À¡C¥»¦¸¡u¦Ñ¦~¤H·ÓÅU¤§¸gÀÙ¦Ò¶q¤Îµû¦ô¤èªk¡v°ê»Ú¬ã°Q·|¬ã°Q¥DÃD¥]¬A¡u¸gÀÙ¬Fµ¦­±³W¹º¹ï¦Ñ¦~¤H·ÓÅUªºÁͶթM¹ê°È¡Ð¿D¬wªº¸gÅç¡v¡B¡u±q¸gÀÙ¬Fµ¦­±¦p¦ó¸¨¹ê¦Ñ¦~¤Hªº·ÓÅU¡Ð¼w°êªº¸gÅç¡v¡B¡u¦p¦óÀ³¥Îµû¦ô¤u¨ã³W¹º¦Ñ¦~¤Hªº·ÓÅU¡v¡B¡u¥xÆW¦a°Ï¦Ñ¦~¤H·ÓÅU¤§°]°È¬Fµ¦¿ï¶µ¤Î¥i¦æ©Ê¡vµ¥¡C

¥xÆW¦Ñ¦~¤H¤f¤ñ¨Ò§Ö³t¼Wªø¡A¦Û¥Á°ê82¦~ªº7%¡A¼W¬°94¦~ªº9.5%¡A¹w­p2020¦~±N¹F14%¡C¤H¤f¦Ñ¤Æ³t«×§Ö¹L¦U¶µ¬ÛÃö°t®M¨î«×ªº³]¸m¡A¬°¦]À³°ê¤º¤H¤f¦Ñ¤Æ°ÝÃD¡A°ê½Ã°|¦Û93¦~¦¨¥ß¦Ñ¦~Âå¾Ç¬ã¨s²Õ¡A¦b­º¥ôÀ¹ªF­ì²Õ¥D¥ôªº±a»â¤U¿n·¥°ö¨|¤H¤~¨Ã¶Ê¤Æ°ê¤º¦Ñ¦~Âå¾Ç¬ÛÃö±¹¬Iªº¸¨¹ê¡C95¦~4¤ë1¤é°_·s¥ô²Õ¥D¥ô¥Ñ³¯¼y¾l±µ¥ô¡A³¯²Õ¥D¥ô´¿¾á¥ô°ê¥ß¥xÆW¤j¾Ç½Ã¥Í²Õ¥D¥ô¡B¥x¤jÂå°|®a®xÂå¾Ç³¡¥D¥ô©M¬Ù¥ß¥x¥_Âå°|°|ªø¡A1995¦~°_¾á¥ô¥x¤jÂå¾Ç°|®a®xÂå¾Ç¬ì±Ð±Â¡A¬°¥xÆW®a®xÂå¾Ç±Ð¨|ªº¥ýÅXªÌ¤§¤@¡C¨ä¥D­n¬ã¨sªº»â°ìµÛ­«©ó¦b¦w¹ç½w©MÂåÀø©M·s³¯¥NÁ¯g­Ô¸s¡A¬°¦Ñ¦~Âå¾Ç¬ã¨s²Õ©Ò»Ý­nµo®iªº»â°ì¡C±q¥ý¶i°ê®aªº¸gÅç¡A¦Ñ¦~ÂåÀø¹Î¶¤ªº²Õ¦¨¥]¬A¦Ñ¤HÂå¾Ç±M¬ìÂå®v¡B®a®xÂå®v¡B¾¯àªvÀø®v¡Bª«²zªvÀø®v¡B¤ß²z®v¡BªÀ¤u®v¥H¤Î§Ó¤u¹ÎÅ骺¥[¤J¡A¬O´£¤É¦Ñ¤H·ÓÅ@«~½èªº¥²­n±ø¥ó¡C³¯¼y¾l²Õ¥D¥ô»P¦Ñ¤H·ÓÅ@¬ÛÃö»â°ì±K¤ÁÃö«Y¥B©~»â¾É¦a¦ì¡A¥²¯à±a°Ê¥xÆW¦Ñ¦~Âå¾Ç¬ã¨sªº«ùÄòµo®i¡C
¡m¤å¡G¿à瑨¸©¡F¹Ï¤@¡G»P·|¶Q»«»Pµ²°V¾Ç­û¦X¼v¡F¹Ï¤G¡G¡u¦Ñ¦~¤H·ÓÅU¤§¸gÀÙ¦Ò¶q¤Îµû¦ô¤èªk¡v°ê»Ú¬ã°Q·|¤º®e¡]·Ó¤ù¥Ñ¦Ñ¦~²Õ´£¨Ñ¡^¡n

¾Ç³N¬¡°Ê
°ê®a½Ã¥Í¬ã¨s°|°|¤º¾Ç³NºtÁ¿¨t¦C¡Ð¦ó¥O§g³Õ¤h¡BªL¨q®S±Ð±Â

¥DÁ¿¤H¡G¦ó¥O§g³Õ¤h (Ling Jun Ho, Ph.D.)
¡@¡@¡@¡@(Assistant Investigator, Division of Gerontology, NHRI, Taiwan)
ºtÁ¿¥DÃD¡GThe Potential Immunomodulatory Drugs in
¡@¡@¡@¡@¡@Osteoarthritis : the Retinoids

®É¶¡¡G2006¦~7¤ë7¤é(¬P´Á¤­) 1:30-3:00 pm

¥DÁ¿¤H¡G
ªL¨q®S±Ð±Â (Shio Jean Lin, M.D.)
(Professor and Director, Division of Genetics and Metabolism, Department of Pediatrics, National Cheng Kung University,
¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@School of Medicine, Tainan)
ºtÁ¿¥DÃD¡GDiscussion on Child Health Policy in Taiwan
®É¶¡¡G2006¦~7¤ë7¤é(¬P´Á¤­) 3:00-4:30 pm
¦aÂI¡GR1-B1222 (B1, Research Building), NHRI Zhunan Campus
¡@¡@¡@°ê½Ã°|¦Ë«n°|°Ï¬ã¨s¤j¼ÓR1-B1222ºtÁ¿ÆU(­]®ß¿¤¦Ë«nÂí¬ì¬ã¸ô35¸¹)
¥D¿ì³æ¦ì¡G°ê®a½Ã¥Í¬ã¨s°|°|¤º¬ã¨s·~°È³B
¥»ºtÁ¿Äݤ½¶}©Ê½è¡AÅwªï¿ãÅD°Ñ¥[¡I¦p¦³ºÃ¸q¡A½Ð³w¬¢°|¤º¬ã¨s·~°È³B ·¨²Q´f¤p©j
¹q¸Ü¡G(037) 246-166 Âà 33002¡F¶Ç¯u¡G(037) 580-784
¡m¤å¡G·¨²Q´f¡F¥ª¹Ï¡G¦ó¥O§g³Õ¤h¡F¥k¹Ï¡GªL¨q®S±Ð±Â¡n

¼v­µ¸`¥Ø
¥Íª«²Î­p»P¥Íª«¸ê°T¬ã¨s²Õ¾Ç³NºtÁ¿¡ÐProfessor Pak Sham

¥DÁ¿¤H¡GProfessor Pak Sham
¡@¡@¡@¡@(Visiting Professor, Department of Psychiatry, Faculty of Medicine,
¡@¡@¡@¡@University of Hong Kong)
Á¿ÃD¡GStatistical Issues in Genetic Disorders in Complex Disorders
®É¶¡¡G¥Á°ê95¦~5¤ë1¤é ¤W¤È9:30¦Ü10:30
¦aÂI¡G°ê½Ã°|¦Ë«n°|°Ï¦æ¬F¤j¼ÓB1²Ä¤»·|ij«Ç
¥D¿ì³æ¦ì¡G°ê®a½Ã¥Í¬ã¨s°|¥Íª«²Î­p»P¥Íª«¸ê°T¬ã¨s²Õ
Æ[¬Ý¼v­µ¸`¥Ø»Ý­n Windows Media Player ½Ð«ö¦¹³B¤U¸ü
¡m¤å¡G¦ó®Ñ½å¡F¹Ï¡GProfessor Pak Sham¡F¼v­µ¾ã²z¡G¿à±R¤å¡B¦ó®Ñ½å¡n